CClinicalTrials.gg
CompletedNCT04049643Updated Apr 17, 2025Results posted

Hearing Aid and Individuals With Cognitive Disorders

An interventional study of Audiologist-based fitting and Service-only Fitting in Presbycusis, Bilateral, Alzheimer Disease 2 Due to Apoe4 Isoform and Mild Cognitive Impairment, sponsored by Yu-Hsiang Wu. Completed at 2 sites in United States. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-04-17.

Sponsored by Yu-Hsiang Wu · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Study summary

This is a pilot study with the aim of evaluating the feasibility of the procedures of a future clinical trial that will help determine the impacts of hearing aid interventions on older patients with Alzheimer's Disease and related dementias (ADRD). In this pilot study individuals with mild or moderate cognitive impairment, as well as their caregivers, will be recruited. Participants will be randomly assigned to three intervention groups: Audiologist-Based Intervention, Service-Only Group, and Device-Only Group. Outcome data will be collected on the how hearing loss and hearing aid impact their lives and caregiver burden 6-week post hearing aid intervention.

Read the detailed description

A disorder that often affect older adults is age-related hearing loss. It is estimated that about two-thirds of persons aged 70 years or older exhibit hearing problems. Left untreated, age-related hearing loss can affect an individual's ability to communicate and to interact with his/her environment and can contribute to psychological symptoms such depression, anxiety, isolation, paranoia, and possibly dementia.

Because (1) the neuropsychiatric symptoms associated with dementia could be exacerbated by poor communication resulting from hearing loss and (2) it has been widely accepted that hearing aids (HAs) are effective in improving communication function and reducing the psychosocial consequences associated with hearing loss for older adults without dementia, it seems reasonable to use HAs to treat the hearing loss of adults with Alzheimer's Disease and related dementias (ADRD). However, it has been argued that because the pathology of ADRD could involve central auditory pathways and nuclei, HAs-the devices that improve audibility at the peripheral level of the auditory system-may not be an effective management for ADRD. To date there is no high-quality evidence to support or negate the benefit of HA intervention on adults with dementia in reducing communication difficulty, dementia-related symptoms, and caregiver burdens. Therefore, the benefit of HA intervention on adults with ADRD remains unknown. Further, the best service model to provide HAs for older adults with ADRD is unknown. On one hand, it is likely that customized HAs fitted by audiologists using best practices could generate optimal outcomes. However, implementing the best-practice audiology services is challenging in this population. On the other hand, recent literature suggests that audiologists could fit low-cost, pre-programmed, non-customized amplification devices to adults with ADRD to reduce the cost of HA intervention, while yielding reasonable outcomes.To date there is no high-quality research rigorously examining the outcome, value, and candidacy of different HA service-delivery models for older adults with ADRD.

This is a pilot study with the aim of evaluating the feasibility of the procedures of a future clinical trial that will help determine the impacts of hearing aid interventions on older patients with ADRD. We expect that at least a total of 30 patients will complete the pilot study. The collected data will provide valuable information for us to formulate or revise the hypotheses, conduct power analysis, and finalize the research protocol for the future clinical trial.

02

Conditions studied

  • Presbycusis, Bilateral
  • Alzheimer Disease 2 Due to Apoe4 Isoform
  • Mild Cognitive Impairment

Keywords

  • Presbycusis
  • Hearing aid
  • Alzheimer Disease
  • Mild Cognitive Impairment
03

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Montreal Cognitive Assessment (MoCA) score lower than 25 points
  • Adult-onset mild-to-moderate sensorineural hearing loss

Exclusion criteria

Exclusion Criteria:

  • Non-native English speaker
  • Prior hearing aid experience
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
17 participants (actual)

Study arms

  • Active comparator
    Audiologist-Based

    In this group, the audiologist-based fitting will be used to provide hearing aids.

    Device: Audiologist-based fitting

  • Experimental
    Service-Only

    In this group, hearing aids that have minimum amplification will be fitted by audiologists.

    Device: Service-only Fitting

  • Experimental
    Device-Only

    In this group, hearing aids will be provided with minimum services from audiologists.

    Device: Device-only fitting

Interventions

  • DeviceAudiologist-based fitting

    Hearing aids will be fitted by audiologists using established procedures.

  • DeviceService-only Fitting

    This intervention group is designed to explore the contribution of amplification devices in hearing aid intervention, which consists of devices and services. In this intervention group, audiological services plus hearing aids that provide minimum amplification will be provided. Specifically, patient participants in this group will receive audiological services (e.g., counselling and education), except that the hearing aids will be set to provide no amplification other than what is needed to overcome any sounds that are dampened by the earpieces.

  • DeviceDevice-only fitting

    This intervention group is designed to explore the contribution of amplification devices in hearing aid intervention, which consists of devices and services. The patient participants in this intervention group will have minimum services regarding the pre-fitting, selection, and orientation of the hearing aids. The participants will have a hearing evaluation, including pure-tone audiometry. The audiologist will select the amplification characteristics and non-custom ear piece based on the audiogram. The audiologist will then briefly orient the participant on how to use the hearing aids and counsel on how to optimize their performance.

05

What researchers measure

Primary outcomes

  1. Hearing Aid Benefit as Measured by the International Outcomes Inventory for Hearing Aids (IOI-HA)

    The IOI-HA is a questionnaire designed to assess the benefits of hearing aids from the user's perspective. The score ranges from 1 (less benefit) to 5 (more benefit).

    Time frame: 6 weeks after the first day participants started using hearing aids.

  2. Change of Daily Activity as Measured by the Lawton Instrumental Activities of Daily Living Scale (IADL)

    The IADL was developed to assess independent living skills, such as feeding, dressing, and food preparation. The score ranges from 0 (low function) to 8 (high function). Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from +8 (indicating a benefit from hearing aids) to -8 (indicating a detrimental effect of hearing aids).

    Time frame: Immediately before hearing aid use and 6 weeks after the first day of hearing aid use

  3. Change of Caregiver Burden as Measured by the "Zarit Burden Interview" (ZBI)

    Caregiver burden will be measured using the ZBI, which is a 22-item questionnaire. The ZBI measures self-reported burden in terms of the degree (from 'never' to 'almost always') to which the caregiver experiences physical, psychological, emotional, social and financial problems as a result of their care-giving role. The score ranges from 0 (little or no burden) to 88 (severe burden). This measure is completed pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -88 (indicating a benefit from hearing aids) to +88 (indicating a detrimental effect of hearing aids).

    Time frame: Immediately before hearing aid use and 6 weeks after the first day of hearing aid use

Secondary outcomes

  1. Change of Hearing Handicap Measured by Hearing Handicap Inventory for the Elderly (HHIE) or Hearing Handicap Inventory for Adults (HHIA)

    The HHIE and HHIA are questionnaires designed to measure perceived hearing handicap. For subjects order and younger 65 years old, the HHIE and HHIA will be used, respectively. The score ranges from 0 (no handicap) to 100 (more handicap) (i.e., lower scores mean less handicap). Participants will complete this questionnaire pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -100 (indicating a benefit from hearing aids) to +100 (indicating a detrimental effect of hearing aids).

    Time frame: Immediately before hearing aid use and 6 weeks after the first day of hearing aid use

  2. Change of Quality of Life as Measured by the Alzheimer's Disease-Related Quality of Life (ADRQL)

    The ADRQL was developed to assess health related quality of life in people with Alzheimer's disease using assessments from family caregivers or professional staff. The score ranges from 0 (worst situation) to 100 (best situation). Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from +100 (indicating a benefit from hearing aids) to -100 (indicating a detrimental effect of hearing aids).

    Time frame: Immediately before hearing aid use and 6 weeks after the first day of hearing aid use

  3. Change of Depression as Measured Using the Geriatric Depression Scale (GDS)

    The GDS a self-report measure of depression in older adults. The short form of the GDS has 15 items. The score ranges from 0 (no depression) to 15 (more depression) Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -15 (indicating a benefit from hearing aids) to +15 (indicating a detrimental effect of hearing aids).

    Time frame: Immediately before hearing aid use and 6 weeks after the first day of hearing aid use

06

Results

Posted Apr 17, 2025
Limitations and caveats
This study faced challenges in recruiting subjects for the Service-Only and Device-Only groups. Since blinding was not feasible, some potential participants chose not to provide consent after learning their group assignment.

Participant flow

Participant flow — Overall Study
MilestoneAudiologist-BasedService-OnlyDevice-Only
Started935
Completed824
Not completed111
Withdrew: Lack of efficacy110
Withdrew: Health concern (unrelated to the intervention of the study)001

Outcome measures

PrimaryHearing Aid Benefit as Measured by the International Outcomes Inventory for Hearing Aids (IOI-HA)

The IOI-HA is a questionnaire designed to assess the benefits of hearing aids from the user's perspective. The score ranges from 1 (less benefit) to 5 (more benefit).

Time frame:
6 weeks after the first day participants started using hearing aids.
Reported as:
Mean · score on a scale
Hearing Aid Benefit as Measured by the International Outcomes Inventory for Hearing Aids (IOI-HA)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Hearing Aid Benefit as Measured by the International Outcomes Inventory for Hearing Aids (IOI-HA)3.9 ± 0.63.4 ± 0.33.7 ± 0.6
PrimaryChange of Daily Activity as Measured by the Lawton Instrumental Activities of Daily Living Scale (IADL)

The IADL was developed to assess independent living skills, such as feeding, dressing, and food preparation. The score ranges from 0 (low function) to 8 (high function). Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from +8 (indicating a benefit from hearing aids) to -8 (indicating a detrimental effect of hearing aids).

Time frame:
Immediately before hearing aid use and 6 weeks after the first day of hearing aid use
Reported as:
Mean · score on a scale
Change of Daily Activity as Measured by the Lawton Instrumental Activities of Daily Living Scale (IADL)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Change of Daily Activity as Measured by the Lawton Instrumental Activities of Daily Living Scale (IADL)1 ± 50 ± 00 ± 0
PrimaryChange of Caregiver Burden as Measured by the "Zarit Burden Interview" (ZBI)

Caregiver burden will be measured using the ZBI, which is a 22-item questionnaire. The ZBI measures self-reported burden in terms of the degree (from 'never' to 'almost always') to which the caregiver experiences physical, psychological, emotional, social and financial problems as a result of their care-giving role. The score ranges from 0 (little or no burden) to 88 (severe burden). This measure is completed pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -88 (indicating a benefit from hearing aids) to +88 (indicating a detrimental effect of hearing aids).

Time frame:
Immediately before hearing aid use and 6 weeks after the first day of hearing aid use
Reported as:
Mean · score on a scale
Change of Caregiver Burden as Measured by the "Zarit Burden Interview" (ZBI)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Change of Caregiver Burden as Measured by the "Zarit Burden Interview" (ZBI)-2.6 ± 5.5-7 ± 2.8-1 ± 7.9
SecondaryChange of Hearing Handicap Measured by Hearing Handicap Inventory for the Elderly (HHIE) or Hearing Handicap Inventory for Adults (HHIA)

The HHIE and HHIA are questionnaires designed to measure perceived hearing handicap. For subjects order and younger 65 years old, the HHIE and HHIA will be used, respectively. The score ranges from 0 (no handicap) to 100 (more handicap) (i.e., lower scores mean less handicap). Participants will complete this questionnaire pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -100 (indicating a benefit from hearing aids) to +100 (indicating a detrimental effect of hearing aids).

Time frame:
Immediately before hearing aid use and 6 weeks after the first day of hearing aid use
Reported as:
Mean · score on a scale
Change of Hearing Handicap Measured by Hearing Handicap Inventory for the Elderly (HHIE) or Hearing Handicap Inventory for Adults (HHIA)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Change of Hearing Handicap Measured by Hearing Handicap Inventory for the Elderly (HHIE) or Hearing Handicap Inventory for Adults (HHIA)-36 ± 20.1-14 ± 11.3-17.5 ± 21.7
SecondaryChange of Quality of Life as Measured by the Alzheimer's Disease-Related Quality of Life (ADRQL)

The ADRQL was developed to assess health related quality of life in people with Alzheimer's disease using assessments from family caregivers or professional staff. The score ranges from 0 (worst situation) to 100 (best situation). Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from +100 (indicating a benefit from hearing aids) to -100 (indicating a detrimental effect of hearing aids).

Time frame:
Immediately before hearing aid use and 6 weeks after the first day of hearing aid use
Reported as:
Mean · score on a scale
Change of Quality of Life as Measured by the Alzheimer's Disease-Related Quality of Life (ADRQL)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Change of Quality of Life as Measured by the Alzheimer's Disease-Related Quality of Life (ADRQL)5.0 ± 8.313.8 ± 301.25 ± 3.9
SecondaryChange of Depression as Measured Using the Geriatric Depression Scale (GDS)

The GDS a self-report measure of depression in older adults. The short form of the GDS has 15 items. The score ranges from 0 (no depression) to 15 (more depression) Participants complete this measure pre-intervention and at 6 weeks post-intervention. The change in scores between pre- and post-intervention are reported, with score changes ranging from -15 (indicating a benefit from hearing aids) to +15 (indicating a detrimental effect of hearing aids).

Time frame:
Immediately before hearing aid use and 6 weeks after the first day of hearing aid use
Reported as:
Mean · score on a scale
Change of Depression as Measured Using the Geriatric Depression Scale (GDS)
score on a scaleAudiologist-BasedService-OnlyDevice-Only
Change of Depression as Measured Using the Geriatric Depression Scale (GDS)-0.85 ± 2.40.5 ± 0.7-0.33 ± 0.57

Adverse events

Collected over Adverse events are monitored for each subject during their participation in the study, which averaged 7 weeks from the time the participants entered the study.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Audiologist-Based0/8 (0%)0/8 (0%)0/8 (0%)
Service-Only0/2 (0%)0/2 (0%)0/2 (0%)
Device-Only0/4 (0%)0/4 (0%)0/4 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Audiologist-BasedService-OnlyDevice-OnlyTotal
Mean72.4 ± 8.274 ± 1.460.5 ± 14.769 ± 11.4
Sex: Female, Male
Sex: Female, Male(Participants)Audiologist-BasedService-OnlyDevice-OnlyTotal
Female2002
Male62412
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Audiologist-BasedService-OnlyDevice-OnlyTotal
Hispanic or Latino0000
Not Hispanic or Latino82414
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Audiologist-BasedService-OnlyDevice-OnlyTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White82414
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Audiologist-BasedService-OnlyDevice-OnlyTotal
United States82414
Hearing loss (pure-tone average)
Hearing loss (pure-tone average)(dB HL)Audiologist-BasedService-OnlyDevice-OnlyTotal
Mean36.8 ± 5.022.1 ± 4.121.9 ± 5.330.4 ± 8.9
07

Study locations

2 sites
  • University of Iowa
    Iowa City, Iowa 52242, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
08

References and documents

Publications

  • Uhlmann RF, Larson EB, Rees TS, Koepsell TD, Duckert LG. Relationship of hearing impairment to dementia and cognitive dysfunction in older adults. JAMA. 1989 Apr 7;261(13):1916-9. PubMed 2926927 ↗
  • Palmer CV, Adams SW, Durrant JD, Bourgeois M, Rossi M. Managing hearing loss in a patient with Alzheimer disease. J Am Acad Audiol. 1998 Aug;9(4):275-84. PubMed 9733237 ↗
  • Palmer CV, Adams SW, Bourgeois M, Durrant J, Rossi M. Reduction in caregiver-identified problem behaviors in patients with Alzheimer disease post-hearing-aid fitting. J Speech Lang Hear Res. 1999 Apr;42(2):312-28. doi: 10.1044/jslhr.4202.312. PubMed 10229449 ↗
  • Mamo SK, Reed NS, Price C, Occhipinti D, Pletnikova A, Lin FR, Oh ES. Hearing Loss Treatment in Older Adults With Cognitive Impairment: A Systematic Review. J Speech Lang Hear Res. 2018 Oct 26;61(10):2589-2603. doi: 10.1044/2018_JSLHR-H-18-0077. PubMed 30304320 ↗
  • Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of Age-Related Hearing Loss With Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-126. doi: 10.1001/jamaoto.2017.2513. PubMed 29222544 ↗
  • Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care. Lancet. 2017 Dec 16;390(10113):2673-2734. doi: 10.1016/S0140-6736(17)31363-6. Epub 2017 Jul 20. No abstract available. PubMed 28735855 ↗
  • Hopper T, Slaughter SE, Hodgetts B, Ostevik A, Ickert C. Hearing Loss and Cognitive-Communication Test Performance of Long-Term Care Residents With Dementia: Effects of Amplification. J Speech Lang Hear Res. 2016 Dec 1;59(6):1533-1542. doi: 10.1044/2016_JSLHR-H-15-0135. PubMed 27973661 ↗
  • Adrait A, Perrot X, Nguyen MF, Gueugnon M, Petitot C, Collet L, Roux A, Bonnefoy M; ADPHA study group. Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers? J Alzheimers Dis. 2017;58(1):109-121. doi: 10.3233/JAD-160792. PubMed 28269769 ↗

Study documents

  • Protocol and statistical analysis plan · Oct 1, 2024
  • Informed consent form · Jan 24, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The proposed research will include data from participants with hearing loss recruited State of Iowa, State of Tennessee and surrounding areas. The final dataset will include self-reported demographic and behavioral data (e.g., questionnaire). Contact the principle investigator for data access.

09

Registry details

Key details

Study ID
NCT04049643
Lead sponsor
Yu-Hsiang Wu
Collaborators
Vanderbilt University Medical Center, National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
Yu-Hsiang Wu (Associate Professor, University of Iowa) — Sponsor-investigator
First posted
Aug 8, 2019
Start date
Dec 1, 2019
Primary completion
Nov 7, 2024
Completion
Nov 7, 2024
Results posted
Apr 17, 2025
Last update
Apr 17, 2025

Study contacts

Yu-Hsiang Wu, PhD
principal investigator · University of Iowa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion